Matteo Cappucci1, Federico Zarco2, Gianluigi Orgera1, Antonio López-Rueda2, Javier Moreno3, Florindo Laurino4, Daniel Barnes2, Marcello Andrea Tipaldi4, Fernando Gomez5, Juan Macho Fernandez2, Michele Rossi1. 1. Unidad de Intervencionismo, Servicio de Diagnóstico por Imagen, Policlínico Universitario S. Andrea Sapienza, Roma, Italia. 2. Sección de Intervencionismo Vascular, Centro de Diagnóstico por Imagen, Hospital Universitario Clinic i Provincial de Barcelona, Barcelona, España. 3. Sección de Diagnóstico Vascular, Centro de Diagnóstico por Imagen, Hospital Universitario Clinic i Provincial de Barcelona, Barcelona, España. 4. Unidad de Diagnóstico de Patología Vascular, Servicio de Diagnóstico por Imagen, Policlínico Universitario S. Andrea Sapienza, Roma, Italia. 5. Sección de Intervencionismo Vascular, Centro de Diagnóstico por Imagen, Hospital Universitario Clinic i Provincial de Barcelona, Barcelona, España. Electronic address: FEGOMEZ@clinic.cat.
Abstract
INTRODUCTION: The aim of this study is to analyze the safety and efficacy of stent-graft endovascular treatment for visceral artery aneurysms and pseudoaneurysms. METHODS: Multicentric retrospective series of patients with visceral aneurysms and pseudoaneurysms treated by means of stent graft. The following variables were analyzed: Age, sex, type of lesion (aneurysms/pseudoaneurysms), localization, rate of success, intraprocedural and long term complication rate (SIR classification). Follow-up was performed under clinical and radiological assessment. RESULTS: Twenty-five patients (16 men), with a mean age of 59 (range 27-79), were treated. The indication was aneurysm in 19 patients and pseudoaneurysms in 6. The localizations were: splenic artery (12), hepatic artery (5), renal artery (4), celiac trunk (3) and gastroduodenal artery (1). Successful treatment rate was 96% (24/25 patients). Intraprocedural complication rate was 12% (4% major; 8% minor). Complete occlusion was demonstrated during follow up (mean 33 months, range 6-72) in the 24 patients with technical success. Two stent migrations (2/24; 8%) and 4stent thrombosis (4/24; 16%) were detected. Mortality rate was 0%. CONCLUSION: In our study, stent-graft endovascular treatment of visceral aneurysmns and pseudoaneurysms has demonstrated to be safe and is effective in the long-term in both elective and emergent cases, with a high rate of successful treatment and a low complication rate.
INTRODUCTION: The aim of this study is to analyze the safety and efficacy of stent-graft endovascular treatment for visceral artery aneurysms and pseudoaneurysms. METHODS: Multicentric retrospective series of patients with visceral aneurysms and pseudoaneurysms treated by means of stent graft. The following variables were analyzed: Age, sex, type of lesion (aneurysms/pseudoaneurysms), localization, rate of success, intraprocedural and long term complication rate (SIR classification). Follow-up was performed under clinical and radiological assessment. RESULTS: Twenty-five patients (16 men), with a mean age of 59 (range 27-79), were treated. The indication was aneurysm in 19 patients and pseudoaneurysms in 6. The localizations were: splenic artery (12), hepatic artery (5), renal artery (4), celiac trunk (3) and gastroduodenal artery (1). Successful treatment rate was 96% (24/25 patients). Intraprocedural complication rate was 12% (4% major; 8% minor). Complete occlusion was demonstrated during follow up (mean 33 months, range 6-72) in the 24 patients with technical success. Two stent migrations (2/24; 8%) and 4stent thrombosis (4/24; 16%) were detected. Mortality rate was 0%. CONCLUSION: In our study, stent-graft endovascular treatment of visceral aneurysmns and pseudoaneurysms has demonstrated to be safe and is effective in the long-term in both elective and emergent cases, with a high rate of successful treatment and a low complication rate.
Authors: Mohammad Koriem Mahmoud Omar; Moustafa H M Othman; Robert Morgan; Abdelkarem Hasan Abdallah; Hany Seif; Mohamed Zidan; Mahmoud Khairallah; Reham Abd El-Aleem Journal: CVIR Endovasc Date: 2021-07-16
Authors: Keith B Quencer; Anthony S Tadros; Keyan B Marashi; Ziga Cizman; Eric Reiner; Ryan O'Hara; Rahmi Oklu Journal: J Clin Med Date: 2018-05-01 Impact factor: 4.241